Joe Gitchell
CEO
PinneyAssociates

Joe Gitchell serves as CEO at PinneyAssociates, with responsibility for client service.

Mr. Gitchell leads efforts supporting regulatory approvals, conducting public policy analysis, developing marketing approaches, devising, refining, and defending claims(including extensive claims challenge support) and providing input on strategic market opportunities and directions. He has worked for clients in the US, Europe, Latin America, Asia and the Middle East. This work has included extensive collaboration with researchers and policy experts around the world. A co-author on almost 40 articles, Mr. Gitchell has been published in journal including Tobacco Control, Preventive Medicine, Addiction, Archives of Internal Medicine, and Morbidity and Mortality Weekly Report.

Mr. Gitchell joined PinneyAssociates in 1993 after graduating magna cum laude from Yale University and working on the 1992 U.S. presidential campaign.

Sessions with Joe Gitchell

14:25 - 15:25
Health care providers, adults who smoke tobacco, and the public at large all have misperceptions about nicotine and the relative risk of non-combustible nicotine products. Misperceptions can lead to health care providers dispensing inaccurate information, motivating policy makers to pass laws that don’t improve public health, and preventing adults who smoke from switching to less harmful smoke-free products. Hear nicotine science, policy, and advocacy experts discuss long-standing misperceptions about nicotine. What misperceptions does the public believe, and where did those misperceptions come from? How can we meaningfully move the public’s understanding of nicotine and smoke-free products without inadvertently promoting use to unintended audiences (i.e., nonusers and youth)? What more can the FDA do to inform healthcare providers, people who smoke, and the public about the continuum of risk of various nicotine products? What can academic researchers do? What about manufacturers?

Moderators

Speakers